ctrl K

Price Alert

Nurix Therapeutics Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

9.89

-0.31 (-3.09%)

At close: Aug 19, 2025, 3:59 PM

9.89

-0.05%

After-hours: Aug 19, 2025, 07:30 PM EDT

Nurix Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is December - November.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	110M	54.63M	64.47M	80.51M
Short-Term Investments	499.59M	233.28M	244.67M	215.21M
Long-Term Investments	n/a	7.42M	63.88M	137.19M
Other Long-Term Assets	4.06M	4.72M	4.92M	3.12M
Receivables	1.5M	n/a	n/a	6.2M
Inventory	n/a	n/a	-1.1M	n/a
Other Current Assets	8.3M	7.59M	9.31M	1.1M
Total Current Assets	619.39M	295.5M	318.45M	311.12M
Property-Plant & Equipment	45.9M	47.95M	29.51M	25.34M
Goodwill & Intangibles	n/a	n/a	-3.3M	-3.33M
Total Long-Term Assets	49.96M	60.09M	98.31M	165.65M
Total Assets	669.34M	355.6M	416.76M	476.77M
Account Payables	11.48M	6.4M	5.06M	6.65M
Deferred Revenue	38.36M	48.1M	37.63M	41.21M
Short-Term Debt	n/a	6.42M	5.53M	3.85M
Other Current Liabilities	36.76M	16.05M	9.14M	5.67M
Total Current Liabilities	95.85M	86.96M	70.66M	66.26M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	46.5M	68.15M	42.41M	68.21M
Total Liabilities	142.35M	155.1M	113.06M	134.47M
Total Debt	28.3M	30.61M	11.96M	13.04M
Common Stock	76K	49K	47K	45K
Retained Earnings	-738.77M	-545.2M	-401.25M	-220.89M
Comprehensive Income	150K	-655K	-4.32M	-608K
Shareholders Equity	526.99M	200.49M	303.7M	342.3M
Total Investments	499.59M	240.7M	308.55M	352.4M